These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17334924)

  • 21. Prediction errors for state occupation and transition probabilities in multi-state models.
    Spitoni C; Lammens V; Putter H
    Biom J; 2018 Jan; 60(1):34-48. PubMed ID: 29067699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the survival function based on the semi-Markov model for dependent censoring.
    Zhao Z; Zheng M; Jin Z
    Lifetime Data Anal; 2016 Apr; 22(2):161-90. PubMed ID: 25772373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An estimator of the survival function based on the semi-Markov model under dependent censorship.
    Lee SY; Tsai WY
    Lifetime Data Anal; 2005 Jun; 11(2):193-211. PubMed ID: 15938546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to account for early overly small risk sets in the analysis of pregnancy outcome data?-Comparison of different methods for stabilizing the Aalen-Johansen estimator.
    Stegherr R; Fietz AK; Hoeltzenbein M; Dathe K; Beyersmann J
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5718. PubMed ID: 37850535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust inference for event probabilities with non-Markov event data.
    Glidden DV
    Biometrics; 2002 Jun; 58(2):361-8. PubMed ID: 12071409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable selection using inverse probability of censoring weighting.
    Kojima M
    Stat Methods Med Res; 2023 Nov; 32(11):2184-2206. PubMed ID: 37675496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of cause of death: Competing risks or progressive illness-death model?
    Lauseker M; Zu Eulenburg C
    Biom J; 2019 Mar; 61(2):264-274. PubMed ID: 30680772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating lifetime or episode-of-illness costs under censoring.
    Basu A; Manning WG
    Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the role of Volterra integral equations in self-consistent, product-limit, inverse probability of censoring weighted, and redistribution-to-the-right estimators for the survival function.
    Strawderman RL; Baer BR
    Lifetime Data Anal; 2024 Jul; 30(3):649-666. PubMed ID: 38512595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data.
    Allignol A; Schumacher M; Beyersmann J
    Biom J; 2010 Feb; 52(1):126-37. PubMed ID: 20140901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data.
    He P; Eriksson F; Scheike TH; Zhang MJ
    Scand Stat Theory Appl; 2016 Mar; 43(1):103-122. PubMed ID: 27034534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobit regression for modeling mean survival time using data subject to multiple sources of censoring.
    Gong Q; Schaubel DE
    Pharm Stat; 2018 Mar; 17(2):117-125. PubMed ID: 29359427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring.
    Chakladar S; Rosin S; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME
    Biometrics; 2022 Jun; 78(2):777-788. PubMed ID: 33768557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved confidence intervals for a difference of two cause-specific cumulative incidence functions estimated in the presence of competing risks and random censoring.
    Scosyrev E
    Biom J; 2020 Oct; 62(6):1394-1407. PubMed ID: 32227361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reweighted estimators for additive hazard model with censoring indicators missing at random.
    Chen X; Cai J
    Lifetime Data Anal; 2018 Apr; 24(2):224-249. PubMed ID: 28766089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sieve estimation in a Markov illness-death process under dual censoring.
    Boruvka A; Cook RJ
    Biostatistics; 2016 Apr; 17(2):350-63. PubMed ID: 26598559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receiver operating characteristic curve estimation for time to event with semicompeting risks and interval censoring.
    Jacqmin-Gadda H; Blanche P; Chary E; Touraine C; Dartigues JF
    Stat Methods Med Res; 2016 Dec; 25(6):2750-2766. PubMed ID: 24803510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On adjustment for auxiliary covariates in additive hazard models for the analysis of randomized experiments.
    Vansteelandt S; Martinussen T; Tchetgen ET
    Biometrika; 2014 Mar; 101(1):237-244. PubMed ID: 28669998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonparametric estimation of transition probabilities in a non-Markov illness-death model.
    Meira-Machado L; de Uña-Alvarez J; Cadarso-Suárez C
    Lifetime Data Anal; 2006 Sep; 12(3):325-44. PubMed ID: 16917736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.